Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease

There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES)...

Full description

Saved in:
Bibliographic Details
Published inKorean circulation journal Vol. 47; no. 3; pp. 354 - 360
Main Authors Kang, Se Hun, Lee, Cheol Whan, Yun, Sung-Cheol, Lee, Pil Hyung, Ahn, Jung-Min, Park, Duk-Woo, Kang, Soo-Jin, Lee, Seung-Whan, Kim, Young-Hak, Park, Seong-Wook, Park, Seung-Jung
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Cardiology 01.05.2017
대한심장학회
Subjects
Online AccessGet full text
ISSN1738-5520
1738-5555
DOI10.4070/kcj.2016.0439

Cover

Abstract There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD. We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m ) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years. Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001). Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed.
AbstractList There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD.BACKGROUND AND OBJECTIVESThere is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD.We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m2) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years.SUBJECTS AND METHODSWe analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m2) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years.Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001).RESULTSMedian follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001).Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed.CONCLUSIONAmong patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed.
Background and Objectives: There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD. Subjects and Methods: We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m2) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years. Results: Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79–1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77–1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85–4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57–1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20–6.96; p<0.001). Conclusion: Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed. KCI Citation Count: 3
There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD. We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m ) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years. Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001). Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed.
Author Kang, Se Hun
Yun, Sung-Cheol
Lee, Pil Hyung
Park, Seung-Jung
Lee, Cheol Whan
Park, Duk-Woo
Ahn, Jung-Min
Park, Seong-Wook
Lee, Seung-Whan
Kim, Young-Hak
Kang, Soo-Jin
AuthorAffiliation 2 Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
1 Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
3 Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: 3 Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– name: 1 Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
– name: 2 Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Se Hun
  surname: Kang
  fullname: Kang, Se Hun
  organization: Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
– sequence: 2
  givenname: Cheol Whan
  surname: Lee
  fullname: Lee, Cheol Whan
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 3
  givenname: Sung-Cheol
  surname: Yun
  fullname: Yun, Sung-Cheol
  organization: Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 4
  givenname: Pil Hyung
  surname: Lee
  fullname: Lee, Pil Hyung
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Jung-Min
  surname: Ahn
  fullname: Ahn, Jung-Min
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Duk-Woo
  surname: Park
  fullname: Park, Duk-Woo
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 7
  givenname: Soo-Jin
  surname: Kang
  fullname: Kang, Soo-Jin
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 8
  givenname: Seung-Whan
  surname: Lee
  fullname: Lee, Seung-Whan
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 9
  givenname: Young-Hak
  surname: Kim
  fullname: Kim, Young-Hak
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 10
  givenname: Seong-Wook
  surname: Park
  fullname: Park, Seong-Wook
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 11
  givenname: Seung-Jung
  surname: Park
  fullname: Park, Seung-Jung
  organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28567085$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002227455$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNptks-PEyEUx4lZ4_7Qo1fDUQ9TgYFhuJh0u-vauEaj65kwDNPSTqECU9Pz_uNL2-1GjVwegc_7fnmPdw5OnHcGgNcYjSji6P1SL0YE4WqEaCmegTPMy7pgeZ087Qk6BecxLhCqKCXiBTglNas4qtkZuJ_44J0KWzgOyeRwuV2rGOFNUF2ybgY3cQSvwjArrvthf_AjGZfgdLXulUsqWe9g5wP8MvTJbkyMpodXNhoVDbQOfstE5iP8bdMcTubZzGr42bbObI_cS_C8U300rx7jBfj58fpu8qm4_XoznYxvC00JTkXT0VZpUxHNS9pg1iDVCsEIxw1uVV0aqpEWXVVpgktGSqFq1bS14owZRDkvL8C7g64LnVxqK72y-zjzchnk-PvdVOKSC1aRzH44sOuhWZlW5xqC6uU62FVu1j7z7xtn51lnIxml-U0iC7x9FAj-12Bikisbtelz14wfosQC0VqIGu-83vzp9WRy_KUMlAdABx9jMJ3U9tD6bG17iZHczUKuZSF3syB3s5Czin-yjsL_5x8AVRW4LA
CitedBy_id crossref_primary_10_1016_j_cpcardiol_2021_100886
crossref_primary_10_1093_icvts_ivaf021
crossref_primary_10_1186_s13019_020_01245_5
crossref_primary_10_1111_hdi_12946
crossref_primary_10_3389_fcvm_2022_802181
crossref_primary_10_1186_s12872_023_03560_w
crossref_primary_10_1111_ijcp_14506
crossref_primary_10_1053_j_semtcvs_2020_11_005
crossref_primary_10_1159_000494116
crossref_primary_10_1007_s11886_021_01453_y
crossref_primary_10_2459_JCM_0000000000001167
crossref_primary_10_4070_kcj_2017_0066
crossref_primary_10_4070_kcj_2017_0075
Cites_doi 10.1056/NEJMoa040316
10.1161/01.CIR.96.6.1761
10.1046/j.1523-1755.1999.0550031057.x
10.1002/ccd.10103
10.1016/j.ahj.2004.10.010
10.1016/j.jacc.2016.04.034
10.1016/j.jacc.2015.06.1334
10.1016/S0735-1097(02)01745-X
10.1016/j.amjcard.2010.03.037
10.1161/CIRCULATIONAHA.105.580084
10.1016/S0735-1097(01)01450-4
10.1253/circj.CJ-08-0088
10.1161/CIRCULATIONAHA.107.750109
10.1161/CIRCULATIONAHA.105.591990
10.1161/CIR.0b013e31823a5596
10.1253/circj.CJ-08-1091
10.1016/j.jacc.2006.11.048
10.1056/NEJMoa071804
10.1093/ndt/12.4.718
10.1056/NEJMoa1211585
10.1161/CIRCULATIONAHA.107.688416
10.1016/S0140-6736(09)60552-3
10.1001/jama.2013.281718
10.1016/j.jacc.2004.12.082
10.7326/0003-4819-150-9-200905050-00006
10.1016/j.jacc.2010.09.022
10.1161/CIR.0b013e31823c074e
10.1016/j.ahj.2005.03.018
ContentType Journal Article
Copyright Copyright © 2017 The Korean Society of Cardiology 2017
Copyright_xml – notice: Copyright © 2017 The Korean Society of Cardiology 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.4070/kcj.2016.0439
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1738-5555
EndPage 360
ExternalDocumentID oai_kci_go_kr_ARTI_1379562
PMC5449529
28567085
10_4070_kcj_2016_0439
Genre Journal Article
GroupedDBID ---
5-W
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EF.
F5P
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
M~E
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c421t-bf4dace62c734b15b0ad995271b1da83e4c0c9f66c2135239a8abd8a755e04773
IEDL.DBID M48
ISSN 1738-5520
IngestDate Tue Nov 21 21:45:40 EST 2023
Thu Aug 21 18:17:31 EDT 2025
Thu Jul 10 22:39:20 EDT 2025
Thu Jan 02 22:20:49 EST 2025
Tue Jul 01 02:56:54 EDT 2025
Thu Apr 24 23:04:11 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Renal insufficiency
Percutaneous coronary intervention
Coronary artery bypass
Coronary disease
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c421t-bf4dace62c734b15b0ad995271b1da83e4c0c9f66c2135239a8abd8a755e04773
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4070/kcj.2016.0439
PMID 28567085
PQID 1904899812
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1379562
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5449529
proquest_miscellaneous_1904899812
pubmed_primary_28567085
crossref_citationtrail_10_4070_kcj_2016_0439
crossref_primary_10_4070_kcj_2016_0439
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-05-01
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 2017-05-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Korean circulation journal
PublicationTitleAlternate Korean Circ J
PublicationYear 2017
Publisher The Korean Society of Cardiology
대한심장학회
Publisher_xml – name: The Korean Society of Cardiology
– name: 대한심장학회
References Levine (10.4070/kcj.2016.0439_ref14) 2011; 124
Laskey (10.4070/kcj.2016.0439_ref17) 2007; 115
Hillis (10.4070/kcj.2016.0439_ref15) 2011; 124
Best (10.4070/kcj.2016.0439_ref2) 2002; 39
Park (10.4070/kcj.2016.0439_ref12) 2011; 57
Hannan (10.4070/kcj.2016.0439_ref16) 2008; 358
Hlatky (10.4070/kcj.2016.0439_ref24) 2009; 373
Chang (10.4070/kcj.2016.0439_ref26) 2016; 68
Lee (10.4070/kcj.2016.0439_ref6) 2008; 72
National Kidney Foundation (10.4070/kcj.2016.0439_ref19) 2002; 39
Javaid (10.4070/kcj.2016.0439_ref9) 2007; 116
Hannan (10.4070/kcj.2016.0439_ref8) 2005; 352
Gruberg (10.4070/kcj.2016.0439_ref20) 2002; 55
Wang (10.4070/kcj.2016.0439_ref29) 2009; 73
Cooper (10.4070/kcj.2016.0439_ref3) 2006; 113
Levey (10.4070/kcj.2016.0439_ref18) 2009; 150
Hillis (10.4070/kcj.2016.0439_ref4) 2006; 113
BARI Investigators (10.4070/kcj.2016.0439_ref23) 2007; 49
Farkouh (10.4070/kcj.2016.0439_ref25) 2012; 367
Ashrith (10.4070/kcj.2016.0439_ref28) 2010; 106
Serruys (10.4070/kcj.2016.0439_ref22) 2005; 46
Blackman (10.4070/kcj.2016.0439_ref1) 2006; 151
Shlipak (10.4070/kcj.2016.0439_ref5) 2001; 38
BARI Investigators (10.4070/kcj.2016.0439_ref10) 1997; 96
Bangalore (10.4070/kcj.2016.0439_ref30) 2015; 66
Deb (10.4070/kcj.2016.0439_ref27) 2013; 310
Ix (10.4070/kcj.2016.0439_ref11) 2005; 149
Anderson (10.4070/kcj.2016.0439_ref21) 1999; 55
Park (10.4070/kcj.2016.0439_ref13) 2008; 117
Joki (10.4070/kcj.2016.0439_ref7) 1997; 12
17433949 - J Am Coll Cardiol. 2007 Apr 17;49(15):1600-6
17470710 - Circulation. 2007 May 1;115(17):2352-7
15917382 - N Engl J Med. 2005 May 26;352(21):2174-83
26361150 - J Am Coll Cardiol. 2015 Sep 15;66(11):1209-20
18413495 - Circulation. 2008 Apr 22;117(16):2079-86
11923033 - J Am Coll Cardiol. 2002 Apr 3;39(7):1113-9
23121323 - N Engl J Med. 2012 Dec 20;367(25):2375-84
22064599 - Circulation. 2011 Dec 6;124(23):e652-735
20643244 - Am J Cardiol. 2010 Aug 1;106(3):348-53
17846304 - Circulation. 2007 Sep 11;116(11 Suppl):I200-6
16098418 - J Am Coll Cardiol. 2005 Aug 16;46(4):575-81
18216353 - N Engl J Med. 2008 Jan 24;358(4):331-41
10027944 - Kidney Int. 1999 Mar;55(3):1057-62
11793497 - Catheter Cardiovasc Interv. 2002 Jan;55(1):66-72
16490821 - Circulation. 2006 Feb 28;113(8):1063-70
21211683 - J Am Coll Cardiol. 2011 Jan 11;57(2):128-37
11527621 - J Am Coll Cardiol. 2001 Sep;38(3):705-11
19414839 - Ann Intern Med. 2009 May 5;150(9):604-12
27364047 - J Am Coll Cardiol. 2016 Jul 5;68(1):29-36
11904577 - Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
9141000 - Nephrol Dial Transplant. 1997 Apr;12 (4):718-23
19303634 - Lancet. 2009 Apr 4;373(9670):1190-7
24240936 - JAMA. 2013 Nov 20;310(19):2086-95
15864241 - Am Heart J. 2005 Mar;149(3):512-9
22064598 - Circulation. 2011 Dec 6;124(23):2574-609
16490816 - Circulation. 2006 Feb 28;113(8):1056-62
9323059 - Circulation. 1997 Sep 16;96(6):1761-9
19443956 - Circ J. 2009 Jul;73(7):1228-34
18724014 - Circ J. 2008 Sep;72(9):1410-8
16368308 - Am Heart J. 2006 Jan;151(1):146-52
References_xml – volume: 39
  start-page: S1
  issue: 2 Suppl 1
  year: 2002
  ident: 10.4070/kcj.2016.0439_ref19
  publication-title: Am J Kidney Dis
– volume: 352
  start-page: 2174
  year: 2005
  ident: 10.4070/kcj.2016.0439_ref8
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040316
– volume: 96
  start-page: 1761
  year: 1997
  ident: 10.4070/kcj.2016.0439_ref10
  publication-title: Circulation
  doi: 10.1161/01.CIR.96.6.1761
– volume: 55
  start-page: 1057
  year: 1999
  ident: 10.4070/kcj.2016.0439_ref21
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1999.0550031057.x
– volume: 55
  start-page: 66
  year: 2002
  ident: 10.4070/kcj.2016.0439_ref20
  publication-title: Catheter Cardiovasc Interv
  doi: 10.1002/ccd.10103
– volume: 149
  start-page: 512
  year: 2005
  ident: 10.4070/kcj.2016.0439_ref11
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2004.10.010
– volume: 68
  start-page: 29
  year: 2016
  ident: 10.4070/kcj.2016.0439_ref26
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2016.04.034
– volume: 66
  start-page: 1209
  year: 2015
  ident: 10.4070/kcj.2016.0439_ref30
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.06.1334
– volume: 39
  start-page: 1113
  year: 2002
  ident: 10.4070/kcj.2016.0439_ref2
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(02)01745-X
– volume: 106
  start-page: 348
  year: 2010
  ident: 10.4070/kcj.2016.0439_ref28
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2010.03.037
– volume: 113
  start-page: 1063
  year: 2006
  ident: 10.4070/kcj.2016.0439_ref3
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.580084
– volume: 38
  start-page: 705
  year: 2001
  ident: 10.4070/kcj.2016.0439_ref5
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(01)01450-4
– volume: 72
  start-page: 1410
  year: 2008
  ident: 10.4070/kcj.2016.0439_ref6
  publication-title: Circ J
  doi: 10.1253/circj.CJ-08-0088
– volume: 117
  start-page: 2079
  year: 2008
  ident: 10.4070/kcj.2016.0439_ref13
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.750109
– volume: 113
  start-page: 1056
  year: 2006
  ident: 10.4070/kcj.2016.0439_ref4
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.591990
– volume: 124
  start-page: 2574
  year: 2011
  ident: 10.4070/kcj.2016.0439_ref14
  publication-title: Circulation
  doi: 10.1161/CIR.0b013e31823a5596
– volume: 73
  start-page: 1228
  year: 2009
  ident: 10.4070/kcj.2016.0439_ref29
  publication-title: Circ J
  doi: 10.1253/circj.CJ-08-1091
– volume: 49
  start-page: 1600
  year: 2007
  ident: 10.4070/kcj.2016.0439_ref23
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.11.048
– volume: 358
  start-page: 331
  year: 2008
  ident: 10.4070/kcj.2016.0439_ref16
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa071804
– volume: 12
  start-page: 718
  year: 1997
  ident: 10.4070/kcj.2016.0439_ref7
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/12.4.718
– volume: 367
  start-page: 2375
  year: 2012
  ident: 10.4070/kcj.2016.0439_ref25
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1211585
– volume: 115
  start-page: 2352
  year: 2007
  ident: 10.4070/kcj.2016.0439_ref17
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.688416
– volume: 373
  start-page: 1190
  year: 2009
  ident: 10.4070/kcj.2016.0439_ref24
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60552-3
– volume: 310
  start-page: 2086
  year: 2013
  ident: 10.4070/kcj.2016.0439_ref27
  publication-title: JAMA
  doi: 10.1001/jama.2013.281718
– volume: 46
  start-page: 575
  year: 2005
  ident: 10.4070/kcj.2016.0439_ref22
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2004.12.082
– volume: 150
  start-page: 604
  year: 2009
  ident: 10.4070/kcj.2016.0439_ref18
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-9-200905050-00006
– volume: 57
  start-page: 128
  year: 2011
  ident: 10.4070/kcj.2016.0439_ref12
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.09.022
– volume: 124
  start-page: e652
  year: 2011
  ident: 10.4070/kcj.2016.0439_ref15
  publication-title: Circulation
  doi: 10.1161/CIR.0b013e31823c074e
– volume: 151
  start-page: 146
  year: 2006
  ident: 10.4070/kcj.2016.0439_ref1
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2005.03.018
– volume: 116
  start-page: I200
  issue: 11 Suppl
  year: 2007
  ident: 10.4070/kcj.2016.0439_ref9
  publication-title: Circulation
– reference: 17470710 - Circulation. 2007 May 1;115(17):2352-7
– reference: 16490816 - Circulation. 2006 Feb 28;113(8):1056-62
– reference: 18216353 - N Engl J Med. 2008 Jan 24;358(4):331-41
– reference: 10027944 - Kidney Int. 1999 Mar;55(3):1057-62
– reference: 24240936 - JAMA. 2013 Nov 20;310(19):2086-95
– reference: 26361150 - J Am Coll Cardiol. 2015 Sep 15;66(11):1209-20
– reference: 11904577 - Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
– reference: 22064599 - Circulation. 2011 Dec 6;124(23):e652-735
– reference: 21211683 - J Am Coll Cardiol. 2011 Jan 11;57(2):128-37
– reference: 16098418 - J Am Coll Cardiol. 2005 Aug 16;46(4):575-81
– reference: 20643244 - Am J Cardiol. 2010 Aug 1;106(3):348-53
– reference: 18724014 - Circ J. 2008 Sep;72(9):1410-8
– reference: 11527621 - J Am Coll Cardiol. 2001 Sep;38(3):705-11
– reference: 17846304 - Circulation. 2007 Sep 11;116(11 Suppl):I200-6
– reference: 27364047 - J Am Coll Cardiol. 2016 Jul 5;68(1):29-36
– reference: 11793497 - Catheter Cardiovasc Interv. 2002 Jan;55(1):66-72
– reference: 22064598 - Circulation. 2011 Dec 6;124(23):2574-609
– reference: 19303634 - Lancet. 2009 Apr 4;373(9670):1190-7
– reference: 19414839 - Ann Intern Med. 2009 May 5;150(9):604-12
– reference: 17433949 - J Am Coll Cardiol. 2007 Apr 17;49(15):1600-6
– reference: 9323059 - Circulation. 1997 Sep 16;96(6):1761-9
– reference: 9141000 - Nephrol Dial Transplant. 1997 Apr;12 (4):718-23
– reference: 19443956 - Circ J. 2009 Jul;73(7):1228-34
– reference: 23121323 - N Engl J Med. 2012 Dec 20;367(25):2375-84
– reference: 11923033 - J Am Coll Cardiol. 2002 Apr 3;39(7):1113-9
– reference: 16368308 - Am Heart J. 2006 Jan;151(1):146-52
– reference: 18413495 - Circulation. 2008 Apr 22;117(16):2079-86
– reference: 15917382 - N Engl J Med. 2005 May 26;352(21):2174-83
– reference: 16490821 - Circulation. 2006 Feb 28;113(8):1063-70
– reference: 15864241 - Am Heart J. 2005 Mar;149(3):512-9
SSID ssj0064429
Score 2.126092
Snippet There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel...
Background and Objectives: There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD)...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 354
SubjectTerms Original
내과학
Title Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/28567085
https://www.proquest.com/docview/1904899812
https://pubmed.ncbi.nlm.nih.gov/PMC5449529
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002227455
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Korean Circulation Journal, 2017, 47(3), , pp.354-360
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1dT9swFLX4kNBeJmBsdAxkpomnpYsdO06eEN9sUxESq8Sb5Tgu66hcSFtEn_fHuTdJC2VM4ilRciNLOXbuOfH1MSFfwk6OzMEGBnIDCBQbwZmNA5maJAM6YpLSial1Fp-2xY9LefloKVS_wMGL0g73k2oXveb97XgXBjzw1ybIkfDbtf2DNVpxE5d5zpNFSEox6rCWmE4oQNYvNyxjCsa3lDys7Db_fXwmPc37ovMS83xeQPkkIx0vk7c1laR7FfYrZM75VbLUqifL35G_B-hOYIoxhjg47I9vgCrTk8J0sNiZ3g2a9LAYXQVH2P3gwgUQ6CFFw2BTrUjyFDgtLRfp3qHJeI8eVhM6tOvpeWXJOqD4L5fWLrv0Zzf3bjyJWyPt46NfB6dBvedCYAVnwwDr9ox1MbcqEhmTWWjyNJVcsYzlJomcsKFNO3FsOQPuFgGkJssTo6R0oVAqek8WfN-7dUIFkLsoMTIXPBSGMwOfC-syy2wu4UuRNcjXyavWtjYkx30xehqECSKjARmNyGhEpkF2puE3lRPH_wI_A25wravROxuPV319XWhQCN81ixRIQt4g2xNYNQwonCUx3vVHAw0MSaAIZRDzoYJ52h5PZKyApDaImukA0wBscPaO7_4uTbulACnK04-vaHeDvOFIHsqyyk9kYViM3CZQn2G2VXbqB1CHAxU
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronary+Artery+Bypass+Grafting+vs.+Drug-Eluting+Stent+Implantation+for+Multivessel+Disease+in+Patients+with+Chronic+Kidney+Disease&rft.jtitle=Korean+circulation+journal&rft.au=Kang%2C+Se+Hun&rft.au=Lee%2C+Cheol+Whan&rft.au=Yun%2C+Sung-Cheol&rft.au=Lee%2C+Pil+Hyung&rft.date=2017-05-01&rft.issn=1738-5520&rft.volume=47&rft.issue=3&rft.spage=354&rft_id=info:doi/10.4070%2Fkcj.2016.0439&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-5520&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-5520&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-5520&client=summon